Medically reviewed by Gagandeep Brar, MDMedically reviewed by Gagandeep Brar, MD The Janus kinase 2 (JAK2) gene directs cells to make the JAK2 protein, which stimulates cell growth and division.

Though INCY's performance in the year so far has been good, increasing competition for Jakafi is a concern. We advise ...

A 45-year-old woman was evaluated in the rheumatology clinic because of possible IgG4-related disease. She had polyclonal ...

An expert explained the importance of education and involvement in care for patients with myeloproliferative neoplasms.

GlobalData’s report assesses the drugs in the Leptin Receptor pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

AVITA's large addressable market, high gross margins, and low valuation suggest the potential for 154% stock upside. Find out ...

Although Jakafi has been approved for patients with higher-risk myelofibrosis, those with lower-risk disease may also benefit ...

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

Our Bureau, Mumbai Thursday, September 26, 2024, 17:50 Hrs [IST] ...